Safety and Pharmacology Study of Atezolizumab Alone and in Combination With Bacille Calmette-Guérin (BCG) in High-Risk Non-Muscle-Invasive Bladder Cancer (NMIBC) Participants
Clinical trial NCT02792192 · TERMINATED
Trial details
- NCT number
- NCT02792192
- Sponsor
- Hoffmann-La Roche
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-13
- Primary completion
- 2020-09-29
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.